GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹8,918 Cr | ₹7,955 Cr | ₹9,508 Cr | ₹8,175 Cr | ₹7,300 Cr |
What is the latest Appropriations of GLENMARK PHARMACEUTICALS ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹8,918 Cr |
| Mar2025 | ₹7,955 Cr |
| Mar2024 | ₹9,508 Cr |
| Mar2023 | ₹8,175 Cr |
| Mar2022 | ₹7,300 Cr |
How is Appropriations of GLENMARK PHARMACEUTICALS Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,918 Cr | 12.09 | |
| Mar2025 | ₹7,955 Cr | -16.33 | |
| Mar2024 | ₹9,508 Cr | 16.30 | |
| Mar2023 | ₹8,175 Cr | 12.00 | |
| Mar2022 | ₹7,300 Cr | - | |
Compare Appropriations of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹67,389.4 Cr | 5.3% | 3.4% | 27.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 5.3% |
3.4% |
27.4% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses